Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs

被引:33
|
作者
Ueno, Takamasa
Idegami, Yuka
Motozono, Chihiro
Oka, Shinichi
Takiguchi, Masafumi
机构
[1] Kumamoto Univ, Div Viral Immunol, Ctr AIDS Res, Kumamoto, Japan
[2] INt Med Ctr Japan, AIDS Clin Ctr, Tokyo, Japan
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 09期
关键词
D O I
10.4049/jimmunol.178.9.5513
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mutational escape of HIV-1 from established CTL responses is becoming evident. However, it is not yet clear whether antigenic variations of HIV-1 may have an additional effect on the differential antiviral effectiveness of HIV-specific CTLs. Herein, we characterized HIV-specific CTL responses toward Pol, Env, and Nef optimal epitopes presented by HLA-B*35 during a chronic phase of HIV-1 infection. We found CTL escape variants within Pol and Nef epitopes that affected recognition by TCRs, although there was no mutation within the Env epitope. An analysis of peptide-HLA tetrameric complexes revealed that CD8 T cells exclusively specific for the Nef variant were generated following domination by the variant viruses. The variant-specific cells were capable of killing target cells and producing antiviral cytokines but showed impaired Ag-specific proliferation ex vivo, whereas wild-type specific cells had potent activities. Moreover, clonotypic CD8 T cells specific for the Pol variant showed diminished proliferation, whereas Env-specific ones had no functional heterogeneity. Taken together, our data indicate that antigenic variations that abolished TCR recognition not only resulted in escape from established CTL responses but also eventually generated another subset of variant-specific CTLs having decreased antiviral activity, causing an additional negative effect on antiviral immune responses during a chronic HIV infection.
引用
收藏
页码:5513 / 5523
页数:11
相关论文
共 50 条
  • [31] CSF FOLLOW-UP IN HIV-1 INFECTION - INTRATHECAL PRODUCTION OF HIV-SPECIFIC AND UNSPECIFIC IGG, AND BETA-2-MICROGLOBULIN INCREASE WITH DURATION OF HIV-1 INFECTION
    ELOVAARA, I
    NYKYRI, E
    POUTIAINEN, E
    HOKKANEN, L
    RAININKO, R
    SUNI, J
    ACTA NEUROLOGICA SCANDINAVICA, 1993, 87 (05): : 388 - 396
  • [32] Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals
    Quayle, AJ
    Coston, WMP
    Trocha, AK
    Kalams, SA
    Mayer, KH
    Anderson, DJ
    JOURNAL OF IMMUNOLOGY, 1998, 161 (08): : 4406 - 4410
  • [33] Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 vaccine Design
    French, Martyn A.
    Tjiam, M. Christian
    Abudulai, Laila N.
    Fernandez, Sonia
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [34] HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses
    Ranasinghe, Srinika
    Soghoian, Damien Z.
    Lindqvist, Madelene
    Ghebremichael, Musie
    Donaghey, Faith
    Carrington, Mary
    Seaman, Michael S.
    Kaufmann, Daniel E.
    Walker, Bruce D.
    Porichis, Filippos
    JOURNAL OF VIROLOGY, 2016, 90 (05) : 2208 - 2220
  • [35] Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
    Ackerman, Margaret E.
    Crispin, Max
    Yu, Xiaojie
    Baruah, Kavitha
    Boesch, Austin W.
    Harvey, David J.
    Dugast, Anne-Sophie
    Heizen, Erin L.
    Ercan, Altan
    Choi, Ickwon
    Streeck, Hendrik
    Nigrovic, Peter A.
    Bailey-Kellogg, Chris
    Scanlan, Chris
    Alter, Galit
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05): : 2183 - 2192
  • [36] A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors
    Blair, WS
    Isaacson, J
    Li, XQ
    Cao, J
    Peng, QH
    Kong, GFZ
    Patick, AK
    ANTIVIRAL RESEARCH, 2005, 65 (02) : 107 - 116
  • [37] Antiviral therapy and the transmission dynamics of HIV-1
    Garnett, GP
    Anderson, RM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 : 135 - 150
  • [38] HIV-1 integrase as a target for antiviral drugs
    Pommier, Y
    Pilon, AA
    Bajaj, K
    Mazumder, A
    Neamati, N
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (06): : 463 - 483
  • [39] Antiviral Inhibition of the HIV-1 Matrix Protein
    Mercredi, Peter
    Bhargava, Pallavi
    Summers, Michael
    PROTEIN SCIENCE, 2012, 21 : 154 - 155
  • [40] Antiviral inhibition of the HIV-1 capsid protein
    Tang, C
    Loeliger, E
    Kinde, I
    Kyere, S
    Mayo, K
    Barklis, E
    Sun, YN
    Huang, MJ
    Summers, MF
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (05) : 1013 - 1020